A phase 2 trial of WF10 in patients with allergic rhinitis.

Trial Profile

A phase 2 trial of WF10 in patients with allergic rhinitis.

Active, no longer recruiting
Phase of Trial: Phase II

Latest Information Update: 21 Dec 2015

At a glance

  • Drugs WF 10 (Primary)
  • Indications Seasonal allergic rhinitis
  • Focus Therapeutic Use
  • Acronyms 2015 WF10 Trial
  • Sponsors Nuvo Research
  • Most Recent Events

    • 21 Dec 2015 According to Nuvo Research media release, the company plans to discontinue this phase 2 trial.
    • 21 Dec 2015 According to Nuvo Research media release, the company announce topline results of WF10 trial for the treatment of allergic rhinitis.
    • 05 Aug 2015 According to Nuvo Research media release, status changed from not yet recruiting to active, no longer recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top